Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Baoling Bio
company
About
Baoling Bio is a biomedical technology company engaged in innovative drug research and industrialization processes.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥106.50M
- Industries
- Biopharma,Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 2019
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Baoling Bio is an innovative drug research and development and industrialization service provider. The company's research and development pipeline covers the research and development of innovative drugs such as tumors (solid tumors and hematomas), autoimmune diseases, and cytokine storms caused by new coronavirus pneumonia.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥106.50M
Baoling Bio has raised a total of
¥106.50M
in funding over 2 rounds. Their latest funding was raised on
Dec 8, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 8, 2021 | Series A | ¥106.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Baoling Bio is funded by 1 investors.
New Value Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
New Value Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
